Evidence map›Paper›PMID 34443447›Full record

ArticleMolecules (Basel, Switzerland)2021

Valorization of Okara by Enzymatic Production of Anti-Fungal Compounds for Plant Protection.

Stefano De Benedetti, Valeria Girlando, Matias Pasquali, Alessio Scarafoni

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Stefano De BenedettiDepartment of Food, Environmental and Nutritional Sciences, University of Milan, 20133 Milan, Italy.ORCID 0000-0002-7787-9645
Valeria GirlandoDepartment of Food, Environmental and Nutritional Sciences, University of Milan, 20133 Milan, Italy.ORCID 0000-0001-6997-4282
Matias PasqualiDepartment of Food, Environmental and Nutritional Sciences, University of Milan, 20133 Milan, Italy.ORCID 0000-0002-9102-2066
Alessio ScarafoniDepartment of Food, Environmental and Nutritional Sciences, University of Milan, 20133 Milan, Italy.ORCID 0000-0003-1970-0122
University of Milan · IT

Funding

Fondazione Cariplo 2018-0983
6 · The paper itself

Abstract

Okara is a soybean transformation agri-food by-product, the massive production of which currently poses severe disposal issues. However, its composition is rich in seed storage proteins, which, once extracted, can represent an interesting source of bioactive peptides. Antimicrobial and antifungal proteins and peptides have been described in plant seeds; thus, okara is a valuable source of compounds, exploitable for integrated pest management. The aim of this work is to describe a rapid and economic procedure to isolate proteins from okara, and to produce an enzymatic proteolyzed product, active against fungal plant pathogens. The procedure allowed the isolation and recovery of about 30% of okara total proteins. Several proteolytic enzymes were screened to identify the proper procedure to produce antifungal compounds. Antifungal activity of the protein digested for 24 h with pancreatin against

Indexed as

Antifungal AgentsEnzymesFreeze DryingFusariumMicrobial Sensitivity TestsMolecular WeightPlant ProteinsPlantsPolysaccharidesProteolysisSoy FoodsSpectrophotometry, UltravioletTrypsinTrypsin InhibitorsAntifungal AgentsEnzymesokara, Glycine maxPlant ProteinsPolysaccharidesTrypsinTrypsin Inhibitorsbioactive peptidesbiotechnologycircular economyokaraproteolysis

Identifiers

PMID34443447
PMCPMC8400248
OpenAlexW3190539426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.